Veeva Systems Strengthens Its Offerings with Copli Acquisition and New MLR Solution

Veeva Systems Acquires Copli to Revolutionize MLR Processes

In an exciting development for the life sciences industry, Veeva Systems (NYSE: VEEV) has announced the acquisition of Copli, the leading innovator in agentic medical, legal, and regulatory (MLR) solutions. This strategic acquisition is set to enhance Veeva's capabilities with the introduction of Veeva Falcon MLR, a cutting-edge solution designed to dramatically improve the content review process.

The advent of Veeva Falcon MLR introduces an extraordinary opportunity for marketing teams and regulatory groups. With a primary goal to minimize manual efforts and accelerate review cycles, this system leverages agentic automation to streamline compliance checks effectively. By integrating rigorous reviews of promotional and medical materials, Veeva Falcon MLR ensures alignment with approved labels and local regulations. Jacob Scheel-Bech, CEO of Copli, expressed optimism regarding this transition, stating, "Our breakthrough with agentic MLR marks a significant shift in commercial and medical content review and approval."

Transforming the Review Process

Traditionally, the MLR process has posed challenges for timely dissemination of essential information to healthcare providers and patients. By now transforming these bottlenecks into efficient workflows, Veeva Falcon MLR aims for an impressive outcome – the potential to reduce manual MLR labor by 70% or more within a five-year span. Emma Hyland, Vice President at Veeva Commercial Content, emphasized the importance of this transformation: "With Veeva Falcon MLR, our customers can expedite the entire review cycle, allowing reviewers to transition from routine labor to strategic advisory roles."

This automation presents a paradigm shift, where intelligent agents work seamlessly alongside existing tools, such as Veeva PromoMats. The implementation of Veeva Falcon MLR is expected to free up valuable resources, offering reviewers the opportunity to engage in more complex tasks that require human judgment and expertise.

Learn More About Veeva Falcon MLR

Veeva is hosting a webinar on July 9 at 10 a.m. ET, where interested companies can learn more about how Veeva Falcon MLR can contribute to improving their MLR processes. This session is crucial for organizations aiming to stay at the forefront of compliance and regulatory efficiency in the life sciences domain. Interested parties can register at FalconMLR.veeva.com to gain insights from industry leaders on utilizing this new solution effectively.

About Veeva Systems

Veeva Systems is committed to delivering innovative solutions tailored for the life sciences sector. The company’s offerings include software, artificial intelligence, data analytics, and strategic consulting, catering to over 1,500 clients, ranging from major pharmaceutical firms to smaller biotech enterprises. Veeva’s vision extends beyond profits; as a Public Benefit Corporation, it strives to balance the interests of its customers, employees, and shareholders.

With the acquisition of Copli and the launch of Veeva Falcon MLR, Veeva Systems is poised to redefine the standards of speed and compliance in content review processes, making it easier for companies to deliver vital medical information to the healthcare field.

Veeva continues to focus on innovation and customer success, reinforcing its commitment to the life sciences community by establishing a future where compliance is not a hindrance, but a streamlined and seamless experience.

Cautionary Note

While this release contains forward-looking statements regarding the anticipated results of the acquisition, it is accompanied by inherent risks and uncertainties. Actual outcomes may differ materially, and stakeholders are encouraged to consider these factors as outlined in Veeva's periodic SEC filings.